Molecular basis of Parry-Romberg syndrome II

Molecular basis of Parry-Romberg syndrome II - PRS II

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45270

Enrollment

Registered

2017-05-22

Start date

2017-08-22

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

progressive hemifacial atrophy

Interventions

etiology

Parry-Romberg syndrome

progressive hemifacial atrophy

Eligibility

Age

12 Years to 64 Years

Inclusion criteria

Inclusion criteria: diagnosis Parry-Romberg syndrome Able to read and understand the information 16 years or older

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Detection of the gene causing Parry-Romberg syndrome using results of studies of RNA in affected and non-affected skin.	—

Secondary

Measure	Time frame
Understanding of the molecular and cellular mechanisms leading to the various manifestations of Parry-Romberg syndrome.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)